Try our beta test site

Valsartan to Prevent Left Ventricle Remodeling in Pacemaker Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2017 by Medical University of Silesia
Sponsor:
Collaborator:
Polpharma Pharmaceutical Company
Information provided by (Responsible Party):
Andrzej Tomasik MD PhD FESC, Medical University of Silesia
ClinicalTrials.gov Identifier:
NCT01805804
First received: March 2, 2013
Last updated: January 1, 2017
Last verified: January 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2019
  Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):